BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 19565921)

  • 1. HSV-TK/IL-2 gene therapy for glioblastoma multiforme.
    Barzon L; Pacenti M; Franchin E; Colombo F; Palù G
    Methods Mol Biol; 2009; 542():529-49. PubMed ID: 19565921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined HSV-TK/IL-2 gene therapy in patients with recurrent glioblastoma multiforme: biological and clinical results.
    Colombo F; Barzon L; Franchin E; Pacenti M; Pinna V; Danieli D; Zanusso M; Palù G
    Cancer Gene Ther; 2005 Oct; 12(10):835-48. PubMed ID: 15891772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune response induced by retrovirus-mediated HSV-tk/GCV pharmacogene therapy in patients with glioblastoma multiforme.
    Rainov NG; Kramm CM; Banning U; Riemann D; Holzhausen HJ; Heidecke V; Burger KJ; Burkert W; Körholz D
    Gene Ther; 2000 Nov; 7(21):1853-8. PubMed ID: 11110418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
    Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
    J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An improved retroviral vector encoding the herpes simplex virus thymidine kinase gene increases antitumor efficacy in vivo.
    Lyons RM; Forry-Schaudies S; Otto E; Wey C; Patil-Koota V; Kaloss M; McGarrity GJ; Chiang YL
    Cancer Gene Ther; 1995 Dec; 2(4):273-80. PubMed ID: 8548581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The biosafety of the HSV-TK/GCV gene therapy in five cases of recurrent glioblastoma multiforme].
    Adachi N; Könü DL; Frei K; Yonekawa Y
    No Shinkei Geka; 2000 Nov; 28(11):965-74. PubMed ID: 11127592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The HSV-TK/GCV gene therapy in five cases of recurrent glioblastoma multiforme].
    Adachi N; Könü DL; Frei K; Yonekawa Y
    No Shinkei Geka; 2000 Oct; 28(10):865-71. PubMed ID: 11070906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different efficacy of in vivo herpes simplex virus thymidine kinase gene transduction and ganciclovir treatment on the inhibition of tumor growth of murine and human melanoma cells and rat glioblastoma cells.
    Berenstein M; Adris S; Ledda F; Wolfmann C; Medina J; Bravo A; Mordoh J; Chernajovsky Y; Podhajcer OL
    Cancer Gene Ther; 1999; 6(4):358-66. PubMed ID: 10419054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene therapy of glioblastoma multiforme via combined expression of suicide and cytokine genes: a pilot study in humans.
    Palù G; Cavaggioni A; Calvi P; Franchin E; Pizzato M; Boschetto R; Parolin C; Chilosi M; Ferrini S; Zanusso A; Colombo F
    Gene Ther; 1999 Mar; 6(3):330-7. PubMed ID: 10435083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of glioblastoma by direct inoculation of concentrated high titer-recombinant retrovirus carrying the herpes simplex virus thymidine kinase gene.
    Ikenaka K; Sasaki M; Tamura K; Tamura M; Miyao Y; Nanmoku K; Kawano Y; Nakahira K; Yoshimine T; Shimizu K
    Hum Cell; 2001 Mar; 14(1):49-58. PubMed ID: 11436353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protease pretreatment increases the efficacy of adenovirus-mediated gene therapy for the treatment of an experimental glioblastoma model.
    Kuriyama N; Kuriyama H; Julin CM; Lamborn KR; Israel MA
    Cancer Res; 2001 Mar; 61(5):1805-9. PubMed ID: 11280727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective treatment of experimental glioblastoma by HSV vector-mediated TNF alpha and HSV-tk gene transfer in combination with radiosurgery and ganciclovir administration.
    Niranjan A; Moriuchi S; Lunsford LD; Kondziolka D; Flickinger JC; Fellows W; Rajendiran S; Tamura M; Cohen JB; Glorioso JC
    Mol Ther; 2000 Aug; 2(2):114-20. PubMed ID: 10947938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced tumor cell killing in the presence of ganciclovir by herpes simplex virus type 1 vector-directed coexpression of human tumor necrosis factor-alpha and herpes simplex virus thymidine kinase.
    Moriuchi S; Oligino T; Krisky D; Marconi P; Fink D; Cohen J; Glorioso JC
    Cancer Res; 1998 Dec; 58(24):5731-7. PubMed ID: 9865731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HSV vector cytotoxicity is inversely correlated with effective TK/GCV suicide gene therapy of rat gliosarcoma.
    Moriuchi S; Krisky DM; Marconi PC; Tamura M; Shimizu K; Yoshimine T; Cohen JB; Glorioso JC
    Gene Ther; 2000 Sep; 7(17):1483-90. PubMed ID: 11001368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase 1-2 clinical trial of gene therapy for recurrent glioblastoma multiforme by tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir. GLI328 European-Canadian Study Group.
    Shand N; Weber F; Mariani L; Bernstein M; Gianella-Borradori A; Long Z; Sorensen AG; Barbier N
    Hum Gene Ther; 1999 Sep; 10(14):2325-35. PubMed ID: 10515452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combined interleukin-2 and herpes simplex virus thymidine kinase gene therapy for head and neck squamous cell carcinoma].
    Liu S; Liang C; Yang H; Xian J
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Dec; 36(6):426-9. PubMed ID: 12761956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bystander-mediated regression of osteosarcoma via retroviral transfer of the herpes simplex virus thymidine kinase and human interleukin-2 genes.
    Walling HW; Swarthout JT; Culver KW
    Cancer Gene Ther; 2000 Feb; 7(2):187-96. PubMed ID: 10770626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast growth factor-2-retargeted adenoviral vector for selective transduction of primary glioblastoma multiforme endothelial cells.
    Gupta V; Wang W; Sosnowski BA; Hofman FM; Chen TC
    Neurosurg Focus; 2006 Apr; 20(4):E26. PubMed ID: 16709032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herpes simplex virus thymidine kinase gene transduction enhances tumor growth rate and cyclooxygenase-2 expression in murine colon cancer cells.
    Konson A; Ben-Kasus T; Mahajna JA; Danon A; Rimon G; Agbaria R
    Cancer Gene Ther; 2004 Dec; 11(12):830-40. PubMed ID: 15359292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms for ganciclovir resistance in gastrointestinal tumor cells transduced with a retroviral vector containing the herpes simplex virus thymidine kinase gene.
    Yang L; Hwang R; Chiang Y; Gordon EM; Anderson WF; Parekh D
    Clin Cancer Res; 1998 Mar; 4(3):731-41. PubMed ID: 9533543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.